Anders Lundin - Q Linea CFO Officer
| QLINEA Stock | SEK 1.18 0.05 4.42% |
CFO
Mr. Anders Lundin was Chief Financial Officer at QLinea AB since 2018. He has more than 20 years experience in financial work and leadership in international organizations operating in the medical technology and pharmaceutical industries. He has previously served as the CFO of a company listed on Nasdaq Stockholm and was also responsible for a listing on the Nasdaq Stock Market in the US and the associated raising of new equity capital. He holds MSc in economics, Uppsala University . Anders Lundin is a founder and member of the board of directors of CFO Akuten AB. since 2018.
| Age | 59 |
| Tenure | 6 years |
| Phone | 46 1 84 44 36 10 |
| Web | https://www.qlinea.com |
Q Linea Management Efficiency
The company has return on total asset (ROA) of (0.3953) % which means that it has lost $0.3953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7175) %, meaning that it generated substantial loss on money invested by shareholders. Q Linea's management efficiency ratios could be used to measure how well Q Linea manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CFO Age | ||
| Donato Spota | Hansa Biopharma AB | 52 | |
| Eva PinottiLindqvist | Camurus AB | 56 | |
Management Performance
| Return On Equity | -0.72 | |||
| Return On Asset | -0.4 |
Q linea AB Leadership Team
Elected by the shareholders, the Q Linea's board of directors comprises two types of representatives: Q Linea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QLINEA. The board's role is to monitor Q Linea's management team and ensure that shareholders' interests are well served. Q Linea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Q Linea's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Lundin, CFO Officer | ||
| Thomas Fritz, Chief Officer | ||
| Jonas Jarvius, CEO Pres | ||
| Tiziana Martino, Chief Medical Officer | ||
| Henrik Jacobsson, Chief Officer | ||
| Ulrika Stolpe, HR Mang | ||
| Mats Gullberg, Vice President Research Director |
QLINEA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Q Linea a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (13.93) % | |||
| Current Valuation | 287.15 M | |||
| Shares Outstanding | 29.21 M | |||
| Shares Owned By Insiders | 12.15 % | |||
| Shares Owned By Institutions | 74.76 % | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 21.31 X | |||
| Revenue | 9.34 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in QLINEA Stock
Q Linea financial ratios help investors to determine whether QLINEA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in QLINEA with respect to the benefits of owning Q Linea security.